Australis Capital Company Top Insiders
| AUSAF Stock | USD 0.0001 0.00 0.00% |
Australis Capital employs about 10 people. The company is managed by 10 executives with a total tenure of roughly 24 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Australis Capital's management performance can provide insight into the company performance.
| Leah Bailey Insider Chief Officer |
| Thomas Larssen Insider Pres ALPS |
Australis |
Australis Capital Management Team Effectiveness
The company has return on total asset (ROA) of (0.1662) % which means that it has lost $0.1662 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.9168) %, meaning that it generated substantial loss on money invested by shareholders. Australis Capital's management efficiency ratios could be used to measure how well Australis Capital manages its routine affairs as well as how well it operates its assets and liabilities.Australis Capital holds a total of 260.91 Million outstanding shares. Australis Capital retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Australis Capital in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Australis Capital, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Australis Capital Workforce Comparison
Australis Capital is rated fifth in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is presently estimated at about 2,630. Australis Capital adds roughly 10.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
Australis Capital Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Australis Capital Price Series Summation is a cross summation of Australis Capital price series and its benchmark/peer.
Australis Capital Notable Stakeholders
An Australis Capital stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Australis Capital often face trade-offs trying to please all of them. Australis Capital's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Australis Capital's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Leah Bailey | Chief Officer | Profile | |
| Thomas Larssen | Pres ALPS | Profile | |
| Paul Larsen | G Counsel | Profile | |
| Terrance Booth | CEO Director | Profile | |
| Jon Paul | Chief Officer | Profile | |
| Brent Reuter | VP Strategy | Profile | |
| Jason Dyck | Chairman Officer | Profile | |
| Roger Sykes | Chief Officer | Profile | |
| Marc Lakmaaker | VP Markets | Profile | |
| Fausto Aceituno | Chief Officer | Profile |
About Australis Capital Management Performance
The success or failure of an entity such as Australis Capital often depends on how effective the management is. Australis Capital management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Australis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Australis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
It undertakes cannabis, as well as horticulture projects in the United States, Canada, Denmark Finland, Iceland, Germany, the Netherlands, Bahrein, the United Arab Emirates, Southeast Asia, and Australia, as well as other jurisdictions. AUSTRALIS CAP operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Australis Capital Workforce Analysis
Traditionally, organizations such as Australis Capital use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Australis Capital within its industry.Australis Capital Manpower Efficiency
Return on Australis Capital Manpower
| Revenue Per Employee | 947.5K | |
| Revenue Per Executive | 947.5K | |
| Net Loss Per Employee | 5M | |
| Net Loss Per Executive | 5M |
Complementary Tools for Australis Pink Sheet analysis
When running Australis Capital's price analysis, check to measure Australis Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Australis Capital is operating at the current time. Most of Australis Capital's value examination focuses on studying past and present price action to predict the probability of Australis Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Australis Capital's price. Additionally, you may evaluate how the addition of Australis Capital to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |